|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gaspar LE, McNamara EJ, Gay EG, Putnam JB,
Crawford J, Herbst RS and Bonner JA: Small cell lung cancer:
Prognostic factors and changing treatment over 15 years. Clin Lung
Cancer. 13:115–122. 2011.PubMed/NCBI
|
|
3
|
Neal JW, Gubens MA and Wakelee HA: Current
management of small cell lung cancer. Clin Chest Med. 32:853–863.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo H, Deng Q, Wu C, et al: Variations in
HSPA1B at 6p21.3 are associated with lung cancer risk and prognosis
in Chinese populations. Cancer Res. 71:7576–7581. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szkorupa M, Klein J, Bohanes T, Neoral C,
Kolek V and Grygárková I: Neoadjuvant chemotherapy and surgical
treatment in advanced stages of non-small cell lung cancer. Rozhl
Chiv. 90:433–439. 2011.PubMed/NCBI
|
|
6
|
Zeng HZ, Qu YQ, Liang AB, et al:
Expression of CD147 in advanced non-small cell lung cancer
correlated with cisplatin-based chemotherapy resistance. Neoplasma.
58:449–454. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Titulaer MK, Siccama I, Dekker LJ, van
Rijswijk AL, Heeren RM, Sillevis Smitt PA and Luider TM: A database
application for pre-processing, storage and comparison of mass
spectra derived from patients and controls. BMC Bioinformatics.
7:4032006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jemal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar
|
|
9
|
Engwegen JY, Gast MC, Schellens JH and
Beijnen JH: Clinical proteomics: searching for better tumour
markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci.
27:251–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mosley K, Tam FW, Edwards RJ, Crozier J,
Pusey CD and Lightstone L: Urinary proteomic profiles distinguish
between active and inactive lupus nephritis. Rheumatology.
45:1497–1504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomosugi N, Kitagama K, Takahashi N, Sugai
S and Ishikawa I: Diagnostic potential of tear proteome patterns in
Sjögren’s syndrome. J Proteome Res. 4:820–825. 2005.
|
|
12
|
Yu Y, Chen S, Wang LS, et al: Prediction
of pancreatic cancer by serum biomarkers using surface-enhanced
laser desorption/ionization-based decision tree classification.
Oncology. 68:79–86. 2005. View Article : Google Scholar
|
|
13
|
Koopmann J, Zhang Z, White N, et al: Serum
diagnosis of pancreatic adenocarcinoma using surface-enhanced laser
desorption and ionization mass spectrometry. Clin Cancer Res.
10:860–868. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Merchant M and Weinberger SR: Recent
advancements in surface enhanced Iaser desorption ionization-time
of fIight-mass spectrometry. Electrophoresis. 21:1164–1177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
World Health Organization. WHO handbook
for reporting results of cancer treatment. World Health
Organization; Geneva: WHO Offset Publication No 48. 1979
|
|
16
|
Japan Lung Cancer Society. Classification
of lung cancer. 1st edition. Kanehara & Co., Ltd; Tokyo: pp.
49–52. 2000
|
|
17
|
Li J, Zhang Z, Rosenzweig J, Wang YY and
Chan DW: Proteomics and bioinformatics approaches for
identification of serum biomarkers to detect breast cancer. Clin
Chem. 48:1296–1304. 2002.PubMed/NCBI
|
|
18
|
Liu Y: Active learning with support vector
machine applied to gene expression data for cancer classification.
J Chem Inf Comput Sci. 44:1936–1941. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin HH, Han LY, Cai CZ, Ji ZL and Chen YZ:
Prediction of transporter family from protein sequence by support
vector machine approach. Proteins. 62:218–231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
UniProt Consortium. The universial protein
resource (Uniprot) in 2010. Nucleic Acids Res. 38:D142–D148.
2010.PubMed/NCBI
|
|
21
|
Lee JH and Chang JH: Diagnostic utility of
serum and pleural fluid carcinoembryonic antigen, neuron specific
enolase and cytokeratin 19 fragments in patients with effusion from
primary lung cancer. Chest. 128:2298–2303. 2005. View Article : Google Scholar
|
|
22
|
Seibert V, Wiesner A, Buschmann T and
Meuer J: Surface-enhanced l aserdesorption ionization
time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip
technology in proteomics research. Pathol Res Pract. 200:83–94.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawai H, Minamiya Y and Takahashi N:
Prognostic impact of S100A9 overexpression in non-small cell lung
cancer. Tumor Biol. 32:641–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang WS, Moon HG, Kim HS, Choi EJ, Yu MH,
Noh DY and Lee C: Proteomic approach reveals FKBP4 and S100A9 as
potential prediction markers of therapeutic response to neoadjuvant
chemotherapy in patients with breast cancer. J Proteome Res.
11:1078–1088. 2012. View Article : Google Scholar
|
|
25
|
Petricoin EF and Liotta LA:
SELDI-TOF-based serum proteomic pattern diagnostics for early
detection of cancer. Curr Opin Biotechnol. 5:24–30. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Somorjai RL, Dolenko B and Baumgartner R:
Class prediction and discovery using gene microarray and proteomics
mass spectroscopy data: curses, caveats, cautions. Bioinformatics.
19:1481–1491. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Furey TS, Cristianini N, Duffy N,
Bednarski DW, Schummer M and Haussler D: Support vector machine
classification and validation of cancer tissue samples using
microarray expression data. Bioinformatics. 16:906–914. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Byvatov E and Schneider G: Support vector
machine applications in bioinformatics. Appl Bioinformatics.
2:67–77. 2003.
|
|
29
|
Jorissen RN and Gilson MK: Virtual
screening of molecular databases using a support vector machine. J
Chem Inf Model. 45:549–561. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wiesner A: Detection of tumor markers with
proteinChip technology. Curr Pharm Biotechnol. 15:45–67. 2004.
View Article : Google Scholar : PubMed/NCBI
|
